Designing Clinical Trials to Assess Antiepileptic Drugs as Monotherapy: Difficulties and Solutions

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.11, 2008-01, pp. : 917-938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selection Criteria for the Clinical Use of the Newer Antiepileptic Drugs

By Deckers C.L.P. Knoester P.D. de Haan G.J. Keyser A. Renier W.O. Hekster Y.A.

CNS Drugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 405-421

Adis International

Access to resources Recommend Favorite

The New Antiepileptic Drugs Pharmacological and Clinical Aspects

Current Pharmaceutical Design, Vol. 6, Iss. 8, 2000-05 ,pp. : 839-860

Bentham Science Publishers

Access to resources Recommend Favorite

Seizures and Antiepileptic Drugs: From Pathophysiology to Clinical Practice

Current Pharmaceutical Design, Vol. 23, Iss. 42, 2018-02 ,pp. : 6376-6388

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials: How to Assess Confounding and Why So

Current Clinical Pharmacology, Vol. 2, Iss. 2, 2007-05 ,pp. : 129-133

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Problems with Generic Antiepileptic Drugs: Comparison of Sustained-Release Formulations of Carbamazepine

By Mayer T.

Clinical Drug Investigation, Vol. 18, Iss. 1, 1999-07 ,pp. : 17-26

Adis International

Access to resources Recommend Favorite